Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.
Gene-Expression, Lymphocyte-Depletion, Mammary-Tumor-Virus-Mouse, Mice, Mice-Transgenic", RNA-Messenger, Receptors-Antigen-T-Cell-alpha-beta, Repetitive-Sequences-Nucleic-Acid", Support-Non-U, S, -Gov't", Support-U, S, -Gov't-P, H, S, ", T-Lymphocytes, Tumor-Virus-Infections
Cell 1992 May; 69(4):637-45.
Endogenous mouse mammary tumor virus (MMTV) proviruses have recently been shown to cosegregate genetically with the minor lymphocyte-stimulating loci, also termed self-superantigens. The antigenic activity has been" localized to the open reading frame (ORF) protein encoded in the long terminal repeat of MMTV. We show here that unlike their nontransgenic littermates, transgenic mice expressing high levels of an ORF protein" derived from the C3H exogenous MMTV specifically delete their V beta 14+ T cells and do not become infected with this virus when it is present in their mother's milk. Thus, it appears that MMTV utilizes cells of the" immune system in its infection pathway, and mice that retain endogenous" MMTVs should be immune to infection by exogenous virus. These results offer possible new approaches to anti-viral therapy or immunization.
Golovkina, T V.; Chervonsky, A; Dudley, J P.; and Ross, S R., " Transgenic mouse mammary tumor virus superantigen expression prevents viral infection." (1992). Faculty Research 1990 - 1999. 357.